These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8485325)

  • 1. Distal splenorenal shunt and insulin secretion, plasma glucagon, and glucose homeostasis in cirrhosis.
    Trevisani F; Bernardi M; Giancane S; Arienti V; Mazziotti A; Cavallari A; Patrono D; Piazzi S; Gozzetti G; Gasbarrini G
    Nutrition; 1993; 9(2):133-9. PubMed ID: 8485325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis.
    Trevisani F; Bernardi M; Arienti V; Scrivano P; Mazziotti A; Cavallari A; Patrono D; Piazzi S; Gozzetti G; Gasbarrini G
    Hepatology; 1994 Feb; 19(2):329-38. PubMed ID: 8294090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of hepatic encephalopathy after distal splenorenal shunt--PTP image and pancreatic hormone kinetics.
    Hashimoto N; Ashida H; Kotoura Y; Nishioka A; Nishiwaki M; Utsunomiya J
    Hepatogastroenterology; 1993 Aug; 40(4):360-4. PubMed ID: 8406306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gluconeogenesis from amino acids in determining fasting and absorptive levels of plasma ammonia in cirrhosis.
    Trevisani F; Bernardi M; Grilli F; De Palma R; Piazzi S; Patrono D; Gasbarrini G
    Am J Gastroenterol; 1988 Jun; 83(6):646-51. PubMed ID: 2897785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
    Holst JJ; Burcharth F; Kühl C
    Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distal splenorenal shunt: preferred treatment for recurrent variceal hemorrhage in the patient with well-compensated cirrhosis.
    Elwood DR; Pomposelli JJ; Pomfret EA; Lewis WD; Jenkins RL
    Arch Surg; 2006 Apr; 141(4):385-8; discussion 388. PubMed ID: 16618897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting.
    Sherwin R; Joshi P; Hendler R; Felig P; Conn HO
    N Engl J Med; 1974 Jan; 290(5):239-42. PubMed ID: 4808927
    [No Abstract]   [Full Text] [Related]  

  • 8. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
    Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E
    Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal hemodynamics, intestinal absorption, and postshunt encephalopathy.
    Rikkers LF
    Surgery; 1983 Aug; 94(2):126-33. PubMed ID: 6879434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the portal perfusion index after low diameter mesocaval interposition and distal splenorenal shunt--a prospective study.
    Paquet KJ; Mercado MA; Klingele H; Klingele R
    Surg Endosc; 1991; 5(4):204-8. PubMed ID: 1805399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma ammonia level in hepatic cirrhosis: role of glucagon.
    Kabadi UM; Eisenstein AB; Konda J
    Gastroenterology; 1985 Mar; 88(3):750-6. PubMed ID: 3881308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portaprival collaterals following distal splenorenal shunt. Incidence, magnitude and associated portal perfusion changes.
    Henderson JM; Gong-Liang J; Galloway J; Millikan WJ; Sones PJ; Warren WD
    J Hepatol; 1985; 1(6):649-61. PubMed ID: 4056359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of splenopancreatic disconnection as a modification of the distal splenorenal shunt, studied in nonalcoholic patients by sequential angiography.
    Nishioka A; Ashida H; Nishiwaki M; Utsunomiya J
    Surg Today; 1997; 27(11):1015-21. PubMed ID: 9413053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of distal splenorenal shunt plus splenopancreatic disconnection on glucose and amino acid metabolism.
    Hashimoto N; Ashida H
    Hepatogastroenterology; 2005; 52(61):274-6. PubMed ID: 15783048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.
    Gerö L; Korányi L; Szalay F; Büki B; Tamás G
    Acta Diabetol Lat; 1982; 19(1):55-64. PubMed ID: 7041501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral glucose and protein load on plasma glucagon and insulin concentrations in small for gestational age infants.
    Salle BL; Ruiton-Ugliengo A
    Pediatr Res; 1977 Feb; 11(2):108-12. PubMed ID: 840499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal vein blood insulin and glucagon are increased in experimental hyperthyroidism.
    Wolf E; Eisenstein AB
    Endocrinology; 1981 Jun; 108(6):2109-13. PubMed ID: 7014195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulsatile insulin secretion into the portal vein in liver cirrhosis].
    Storch MJ; Rössle M; Kerp L
    Dtsch Med Wochenschr; 1993 Feb; 118(5):134-8. PubMed ID: 8432232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
    Shankar TP; Fredi JL; Himmelstein S; Solomon SS; Duckworth WC
    Am J Med Sci; 1986 Apr; 291(4):248-54. PubMed ID: 3518447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ultrasonic duplex system facilitates detection of portal hemodynamic changes following selective shunts for esophageal varices.
    Iwanaga T; Hashizume M; Koyanagi N; Kitano S; Sugimachi K; Inokuchi K
    Hepatogastroenterology; 1988 Apr; 35(2):73-7. PubMed ID: 3286443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.